| Literature DB >> 27761111 |
Daniel V Guebel1, Néstor V Torres2.
Abstract
Motivation: In the brain of elderly-healthy individuals, the effects of sexual dimorphism and those due to normal aging appear overlapped. Discrimination of these two dimensions would powerfully contribute to a better understanding of the etiology of some neurodegenerative diseases, such as "sporadic" Alzheimer.Entities:
Keywords: aging; autophagia; hippocampus; microRNAs; microarray; mitochondria; senescence; sexual differences
Year: 2016 PMID: 27761111 PMCID: PMC5050216 DOI: 10.3389/fnagi.2016.00229
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.750
Figure 1Sequence of operations performed upon the microarray data to achieve separated networks corresponding to genetic regulation, protein-protein interactions (PP), and metabolic regulation at two different levels of complexity (augmented and core network), for each one of the conditions analyzed (sex ratio positive and negative, age ratio positive and negative, and interaction positive and negative).
Figure 2Venn diagram showing how the data of microarray GSE11882 (Berchtold et al., . The factorial micro-array analysis allows to identify; (A) Genes operating under the age-sex interaction mode; (B) Genes operating under the sex-dependent mode; (C) Genes operating under the age-dependent mode. The values between parentheses indicate the level of False Discovery Rate (FDR) associated to each class of genes.
Figure 3Networks isolated as strongly connected components (SCC) from the Protein-Protein (P-P) connections identified in nucleus 1 under the interaction mode. The nucleus 1 is the network that arises from known inter-relationships between nodes without need to add any additional connector to the list of differential genes detected. (A) Case of positive interaction (n = 229 nodes); (B) Case of negative interaction (n = 549 nodes).
Main functionalities derived from the ontology analysis practiced on the strongly connected components (SCC) corresponding to the interaction-dependent mode (for details see the Table .
| NGF signaling | 5.1 × 10−8 | NGF signaling | 3.3 × 10−14 |
| Positive regulation of anti-apoptotic-mechanisms | 1.4 × 10−5 | Positive regulation of anti-apoptotic-mechanisms | 4.1 × 10−8 |
| Induction of apoptosis (Neuron, B-cells) | 2.1 × 10−4 | Induction of apoptosis (Endothelial cells) | 5.9 × 10−6 |
| Coagulation, haemostasis | 1.4 × 10−7 | Regulation cell cycle arrest (G1/S, G2/M, Mitosis) | 3.4 × 10−6 |
| Synaptosome | 1.4 × 10−6 | Dendrite | 2.9 × 10−8 |
| Positive regulation of GABAergic transmission | 1.2 × 10−4 | Axogenesis, axon guidance | 8.1 × 10−7 |
| Cell senescence | 2.5 × 10−4 | Negative regulation cell communication | 2.1 × 10−6 |
| Cell-cell adherens junctions | 1.5 × 10−5 | Memory | 2.5 × 10−6 |
| Response to oxygen level | 1.3 × 10−3 | Response to hypoxia | 8 × 10−6 |
| Endothelial proliferation, and migration. Blood Brain Barrier establishment | 2.5 × 10−2 | Endothelial cell differentiation and migration | 5.1 × 10−3 |
| Response to UV and radiation. DNA damage | 1.9 × 10−3 | p53 binding | 1.9 × 10−6 |
| Negative regulation of IGFR signaling | 3 × 10−6 | Wnt receptor signaling | 3.4 × 10−6 |
| Cytoskeleton organization | 1.2 × 10−3 | Actin cytoskeleton, Spectrin | 1.1 × 10−5 |
| Response to steroids, androgens, progesterone | 8.4 × 10−4 | Response to insulin and nutrient level | 1.9 × 10−5 |
| Ribonucleotides tri- and bi-phosphate catabolism | 1.1 × 10−3 | Chaperone-mediated protein processes | 2.7 × 10−5 |
| Neurogenesis/Neuroblast proliferation | 1.5 × 10−2 | Plasma membrane organization, Rafts | 3.1 × 10−5 |
| Negative regulation of astrocytes differentiation | 2.2 × 10−3 | Sex Differentiation, Steroid response | 4.2 × 10−5 |
| Astrocytes migration | 1.8 × 10−4 | Nitric Oxide production, NOS1, NOS3, Arginine | 4.5 × 10−5 |
| Microglia activation | 1.3 × 10−3 | Inflammatory response (IL-12, IFNG) | 5.9 × 10−5 |
| Inflammatory response (IL6) | 6.6 × 10−4 | TGFB receptor activity | 5.8 × 10−5 |
| Anti-inflammatory response (IL-10, IL8) | 1.1 × 10−3 | Mononuclear cell proliferation | 3.8 × 10−7 |
| Inmunological response | 1.1 × 10−5 | Inmunological response | 3.4 × 10−5 |
The probabilities values are corrected for the multi-comparisons. In addition, the values indicated are the averages of the probabilities along the several ontology categories that make up each sub-group defined, but weighted according to the relative frequency in which the initial ontology classes appeared from the analysis.
Main functional classes at the protein-protein (P-P) level prevailing by the Age Ratio.
| Anti-apoptotic mechanisms | 4.4 × 10−4 | 5.2 × 10−8 |
| Apoptosis induction | 4.1 × 10−2 | 2.6 × 10−4 |
| Platelet activation, blood coagulation | 7.8 × 10−3 | 9.7 × 10−7 |
| NGF signaling | 1.3 × 10−3 | 1.6 × 10−7 |
| Laminin 5 and 2 Complex | 3.0 × 10−6 | |
| Response to hypoxia | 1.9 × 10−2 | 8.5 × 10−6 |
| Kainate selective glutamate receptors | 3.4 × 10−2 | 1.1 × 10−3 |
| Axogenesis, axon guidance | NDAS | 1.9 × 10−3 |
| Dendritic spines | NDAS | 2.2 × 10−2 |
| Cell aging | NDAS | 4.2 × 10−3 |
| Nitric oxide production | 4.0 × 10−2 | 5.4 × 10−3 |
| Response to nutrients | 2.8 × 10−2 | 7.8 × 10−3 |
| Endothelial cell, vascular development, VEGFR activity | 2.4 × 10−2 | 5.7 × 10−3 |
| Cholesterol, lipoprotein for lipids transport | 3.5 × 10−4 | 1.5 × 10−3 |
| Golgi transport complex, vesicles (endosome, coated, endocytic) | NDAS | 9.5 × 10−3 |
| Response to DNA damage | 6.0 × 10−3 | 1.1 × 10−3 |
| Response to steroids | 3.0 × 10−3 | 1.3 × 10−2 |
| Mineralocorticoid response | 9.1 × 10−2 | 1.5 × 10−4 |
| Acute inflammatory response | 1.79 × 10−1 | 1.7 × 10−4 |
| Leukocyte chemotaxis, response to LPS, defense against virus | 1.1 × 10−1 | 5.5 × 10−3 |
| Monocyte activation | NDAS | 5.2 × 10−2 |
| TGFbeta production | 1.1 × 10−1 | 1.0 × 10−5 |
| Interleukin IL-1 | 1.1 × 10−1 | 6.1 × 10−3 |
| TNFsuperfamily | 1.1 × 10−1 | 1.6 × 10−2 |
| Interleukin IL-4 | 2.7 × 10−1 | 3.0 × 10−4 |
| Interleukin IL-6 | 3.6 × 10−3 | 6.1 × 10−4 |
| Interleukin IL-8 | 2.4 × 10−2 | 1.8 × 10−4 |
| Interleukin IL-10 | 9.6 × 10−2 | 6.1 × 10−3 |
| IFNG production | 2.5 × 10−2 | 1.0 × 10−3 |
| Interleukin IL-18 | NDAS | 5.2 × 10−2 |
| Interleukin IL-23 | 3.4 × 10−2 | 6.1 × 10−3 |
Functionalities are derived by ontology analysis of the compatible P-P networks computed on the basis of those corresponding to the nucleus 1, which comes from the whole list of age-dependent genes (for details see the Table .
The hypergeometric probabilities are values corrected for the multi-comparisons. In addition, the values indicated are the averages of the probabilities along the several ontology categories that make up each sub-group defined, but weighed according to the relative frequency of the initial ontology classes that resulted from the analysis;
NDAS, no-detected as significant.
Differential ontology classes at the protein-protein (PP) level for the sex-dependent genes.
| Anti-apoptotic mechanisms | 8.2 × 10−3 | 6.6 × 10−11 |
| Apoptotic mechanisms | 2.8 × 10−2 | 3.6 × 10−4 |
| Blood coagulation, platelet activation | 1.6 × 10−5 | 6.6 × 10−11 |
| NGFR signaling | 3.5 × 10−4 | 1.6 × 10−8 |
| FGFR signaling | 4.0 × 10−4 | 4.4 × 10−6 |
| Thyroid hormone receptor | 4.6 × 10−3 | 1.2 × 10−6 |
| Smoothened signaling | 1.9 × 10−1 | 4.1 × 10−3 |
| Superoxide formation/remotion | 8.9 × 10−2 | 4.0 × 10−3 |
| SWI/SNF complex, WINAC complex | 1.2 × 10−6 | 1.6 × 10−1 |
| Axogenesis, axon guidance | 1.1 × 10−4 | 6.3 × 10−5 |
| Schwann cell proliferation and differentiation | NDAS | 1.0 × 10−3 |
| Pyramidal neuron development and differentiation | NDAS | 1.1 × 10−3 |
| Response to hypoxia | 7.7 × 10−2 | 3.0 × 10−4 |
| Response to insulin | 4.3 × 10−3 | 2.5 × 10−4 |
| mRNA processing and stability | 1.4 × 10−2 | 2.0 × 10−3 |
| mRNA splicing | 1.9 × 10−2 | 3.6 × 10−2 |
| mRNA silencing | NDAS | 8.5 × 10−3 |
| Steroid hormone signaling | 1.6 × 10−3 | 1.48 × 10−2 |
| Androgen receptor signaling | 6.4 × 10−3 | 1.6 × 10−1 |
| Complement activation, C3 membrane attack | 1.6 × 10−5 | 7.4 × 10−1 |
| Wnt receptor | 2.9 × 10−3 | 2.2 × 10−2 |
| beta-catenin-APC complex | 2.3 × 10−4 | NDAS |
| Non-canonical Wnt signaling | 1.3 × 10−1 | 3.8 × 10−2 |
| TGFbeta signaling | 6.3 × 10−3 | 1.7 × 10−4 |
| IL1-alpha | NDAS | 3.5 × 10−3 |
| IL-1 beta | 4.5 × 10−2 | NDAS |
| IL-1R antagonist | 8.4 × 10−3 | NDAS |
| Tumor Necrosis Factor | 3.5 × 10−1 | 3.1 × 10−3 |
| Mastocytes cytokine production | 4.0 × 10−3 | |
| Endothelial cell migration | 3.6 × 10−2 | 8.6 × 10−6 |
Functionalities are derived by ontology analysis of the compatible P-P networks computed on the basis of the corresponding Nucleus 1 from the whole set of specified genes (for details see the Table .
The hypergeometric probabilities are values corrected for the multi-comparisons. In addition, the values indicated are the averages of the probabilities along the several ontology categories that make up each sub-group defined, but weighed according to the relative frequency of the initial ontology classes that resulted from the analysis;
NDAS, no-detected as significant.
Figure 4Correspondence among the genes detected as differentially expressed under the different modes identified after Q-GDEMAR factorial analysis without summarization and the genes identified in three independent sources of data.
Figure 5Comparison between the core of circuits leading to senescence depending on the type of interaction. (A) Network arising from the nodes with negative value of super-ratio coefficient. (B) Network arising from the nodes with positive value of super-ratio coefficient. The nodes fulfilling the condition imposed (sign of the significant super-ratio values) are colored in gray, while colorless nodes represent genes not detected as differentially expressed. These have been added by the computing algorithm for the sake of network completeness because they have well-known interactions with some of the gray nodes.
Figure 7Comparison between the core of the circuits leading to senescence depending on the sex effect. (A) Network arising from the genes differentially expressed in the group of “Males”; (B) Network arising from the genes differentially expressed in the group of “Females.”
Main differential features of mitochondrial genes resulting from their age- and/or sex-dependence of several processes in which they are involved (For details see Table .
| Fission | MFF, MTFP1, MTFR2, USP44 | NM6, INF2 | MTFR1, MTFR2, MIEF1, NME6 |
| Mitochondrial ribosome (small sub-unit) | MRPS24,MRSP21,MRSP12 | MRPL42,MRPS22,MRPS17 | MRPS22, MRPL42 |
| Mitochondrial ribosome (large-sub-unit) | MRP55,MRPS31,MRPS24, MRPS14, MRPL53, MRPL50, MRPL19, MRPL15 | MRLP3, MRPL16 | MRPL51, MRPL23, MRL11 |
| tRNA processes | RARS2, HARS2, CARS2 | DARS2, EARS2, RARS2, QARS | SARS2, RARS2, EARS2, DARS2, CARS2, QARS |
| Translation factors | GFM1, TSFM, MTER4 | GFM1, TUFM | GFM2, TUFM, MTO |
| Targeting protein to mitochondria | TOMM34, POLRMT, GFM1, HSP90AA1 | TIMM8A | TIMM22, TIMM21, TIMM10B, NFKBIL1, |
| Mitochondrial carriers | SLC3A2 (neutral, aromatic and branched aliphatic amino-acids) | SLC25A22 (L-Glutamate), SLC1A2 (D-Aspartate), SLC25A19 (Thiamine pyrophosphate), SLC25A24 (glucose, insulin-responsive), SLC25A28 (iron), SLC25A29 (carnitine) | SLC25A32 (Folate carrier), SLC25A31 (Adenin-nucleotides) |
| Mitochondria organization | TOMM34, POLRMT, GFM1, HSP90AA1 | TK2, NOS | TK2, SOD2, GFM2, AIFM2, TP53, JUN, NOS3, NDUSFS8 |
| ATPase coupled H+ movement | ATP5C1, ATP5L, ATP5I, | ATP5C1, ATP5D, ATP5B, ATP5H, ATP5I | ATP5H, ATP5D |
| Response to ROS | UCP3 | UCP2 | SOD2 |
| Terminal respiratory chain | UQCRC2 | UQCRC2, NDUFB9 | NDUFS8, CYCS |
| Aerobic respiration | ME3, MDH2, IDH2, UQCRC2 | MDH2, ACO2, CS | |
| Tricarboxylic acid cycle | MDH2, IDH2 | ACO2, CS, IDH1 | MDH2, ACO2, CS |
| Mitochondrial genome maintenance | TK2 | TK2, TYMS, TP53 | |
| Mitochondrial DNA duplication | TK2, DUT | TK2, JUN, TYMS | |
| Apoptosis mitochondrial DNA changes | APOPT1 | CYCS | AIFM2, CYCS, JUN, SOD2 |
| Anti-apoptosis | NME6, NOS3 | SOD2, NME6, NOS3 | |
| Short-chain fatty acid biosynthesis | HMGCS2 | OXSM | HMGCS2 |
Figure 8Distribution of ontology classes in the mitochondrial genes identified by the microarray analysis, according to their association to sex, age, and interaction effects (the values of the FDR associated to each ontology class were corrected for the multiple comparisons).
Disaggregation of effects of sex, age, and sex-age interaction on autophagy and its regulators.
| Rheb | +3.53 | +1.29 | +1.68 |
| MTOR | −1.73 | ||
| RPTOR | +1.80 | ||
| AKT1S1 (PRAS40) | −1.40 | ||
| TTI2 | +1.56 | ||
| DEPTOR | +1.64 | −1.83//+1.30 | |
| RICTOR | +1.27//+1.36 | −1.37 | |
| MAPKAP1 (mSIN1) | +1.24 | ||
| PTEN | +2.1 | ||
| TSC1 | +1.19 | ||
| TSC2 | +1.21 | +1.25 | |
| PRKAA1 (AMPK) | −1.52 | ||
| PRKAA2 (AMPK) | +2 | ||
| ULK1 (ATG1) | −1.31 | ||
| ATG13 | +1.61 | ||
| ATG2A | +1.20 | ||
| ATG2B | +1.46 | +1.19 | |
| ATG4C | +1.45 | ||
| ATG4D | +1.24 | ||
| BECN1(ATG6) | +1.29 | ||
| BCL2 | −1.86 | +1.39 | |
| CALCOCO2 (NDP52) | −1.51 | ||
| MAP1LC3B1 (LC3) | −1.69 | ||
| MAP1LC3B2 (LC3) | −2 | ||
| LAMTOR3 | +1.55 | ||
| LAMTOR2 | +1.20 | ||
| LAMP1 | +1.48 | ||
| LAMP2 | −2.30 | ||
| LAMP5 | −1.33 | ||
| PTEN | +2.1 | ||
| PINK1 | −2.65 | ||
| PARK2 | +2.1 | ||
| SMURF1 | −1.88 | ||
| HSPB8 | −2.63 | ||
| MFN1 (Mitofusin 1) | −1.27 | ||
| VDAC1 | +1.28 | ||
| VDAC3 | +1.93//+1.79 | ||
| BNIP3L | +1.18 | ||
| BNIP1 | +1.18 | ||
| RNF185 | +1.54 | +1.74 | |
| MAP1LC3A (LC3) | −1.69 | ||
| MAP1LC3B2(LC3) | −2 | ||
| TBK1 (TANK-binding Kinase 1) | −2.75 | ||
| HDAC6 | −1.94 | −1.52 | |
Figure 9Simplified diagram mapping the process of mitophagy in relation to the general machinery of autophagy. The specifically dysregulated genes are marked with asterisk. The blue arrows indicate positive regulation, whereas the red arrows indicate inhibitory effects (For numeric details and disaggregation effects, see Table 5). In mitophagy, there are two complementary mechanisms. One is Parkin-independent, comprising the Drp1 path, (Kageyama et al., 2014) and the RNF185-BNIP1 path (Tang et al., 2011), whereas the other is a group of Parkin-dependent variants: the PARK2-BINP3-NRB1 path (Lee et al., 2011; Pratt and Annabi, 2014), PARK2-BINP3L path (Gao et al., 2015), PARK2-SMURF1 path (Orvedahl et al., 2011). This last path is also used to degrade viral capsids. Actually, the Parkin-independent process is driven by the Dynein-related Protein 1 (Drp1) and regulated through the process of mitochondrial fission (see Section Impact of Sexual Dimorphism and Aging on Mitochondrial Function). It aims to diminish the size of the damaged mitochondria to facilitate their engulfment. Importantly, the PARKIN-dependent mitophagy variants require of the proteins PINK1 (Vives-Bauza et al., 2010), and some of the VDACs isoforms (Sun et al., 2012) to be effective. Both proteins contribute to the recruitment of PARK2 from the cytoplasm to the mitochondria. The mitochondrial PARK2 acts as E3Ub ligase on several adaptor molecules, triggering mitophagy. In addition, note that where PARKIN2 route is used, a final set of proteins such as HDAC6 (Lee et al., 2010) and TBK1 together with SQSTML1 (Matsumoto et al., 2015), which allows the step of engulfment of the mitochondrion.
Classification of the microRNAs detected as differentially expressed, according to the type of associated effect (Interaction, age, sex).
| miR-205 | +2.44 | CDH1, ZEB1/2, ERRB3, AKT | Carraway et al., |
| miR-155 | +1.90 | Inhibits negative regulators of inflammation (SHIP1, SOCS) | Elton et al., |
| miR-10b | +1.48 | HOXA1 and NFKB | Fang et al., |
| miR-31 | +1.38 | ICAM1, E-Selectin | Suárez et al., |
| miR-181 | −1.60 | Zeb2, MCL1, BCL2L11, BCL2,PTEN, DUSP6, PTPN11 | Pati et al., |
| miR-17 | −1.83 | APP, TGFBRII, SMAD2, SMAD4, p21, BIM (BCL2L11), PTEN. | Mogilyansky and Rigoutsos, |
| miR-137 (1558034_s_at) | −7.09 | CSMD1, C10orf26, CACNAC1, TCF4, CPLX1, NSF, SYN3, SYT1, BMP6, TGFB2, BAG3, GRIA1 (AMPA), KDM4 | Smrt et al., |
| miR-4458 | 1.82 | Hexokinase | Qin et al., |
| miR-4697 (227084_at) | 1.54 | Risk for Parkinson by SNP, ERBB2 | Persson et al., |
| miR-99a (231832_at) | 1.36 | CDK6, Cyclin D | Tao et al., |
| miR-4435 | +1.27 | 474 predicted targets | |
| miR-143 | +1.18 | KRAS, NRAS (neuroblast RAST), ERK, PI3K/AKT, p65 (NFKB), PRKCE, MAPK7 (ERK5), PDGFRA | Pati et al., |
| miR-Let7b | 1.18 | CCND (Cycline D) and c-Myc | NCBI gene |
| miR-Let7d | −1.36 | BDNF | Giannotti et al., |
| miR-137 (1558028_x_at) | −1.36 | Risk of schizophrenia by SNP, CSMD1, C10orf26, CACNAC1, TCF4, CPLX1, NSF, SYN3, SYT1, BMP6, TGFB2, BAG3, GRIA1 (AMPA), axonal guidance, EPH receptor signaling, LTP | Smrt et al., |
| miR-4435 | −1.53 | No data but present in B cell lymphocytes | Jima et al., |
| miR-600 | −2.07 | 236 predicted targets | |
| miR-124-2 (212927_at) | 1.47 | BDNF, CREB1, Nurr7 | Giannotti et al., |
| miR-99a (231832_at) | 1.60 | CDK6, Cyclin D | Tao et al., |
| miR-663a | 1.46 | CDK6, FBXL18 | Shu et al., |
| miR-4697 (225169_at) | 1.33 | Parkinson risk, ERBB2 | Persson et al., |
| miR-4435 (227674_at) | 1.56 | Present in B cell lymphocytes | Jima et al., |
| miR-4435 (221519_at) | 1.27 | Present in B cell lymphocytes | Jima et al., |
| miR-4435 (1560119_at) | −1.32 | Present in B cell lymphocytes | Jima et al., |
| miR-124-2 (230021_at) | −1.27 | BDNF, CREB1, Nurr77 | Giannotti et al., |
When necessary, below the names of the microRNAs, the code of the probe variant for which the effect was observed appears between parentheses.